A potential vaccine made the markets go round - Tuesday Review, August 25

By: Miguel A. Rodriguez

09:45, 14 September 2020

The global markets were high on hope

The US

The benchmarks have been pushed higher by a possible COVID-19 #vaccine and Jerome Powell's speech due on Thursday. USA30 fell 0.21%, while USA500 rose 0.36%. TECH100 closed at an all-time high after it gained 0.76%.

#Oil prices reached their highest level in almost six months as Hurricane Laura nearly hit a couple of refineries in the US. Crude Oil added 1.9% to $43.56 per barrel, while Brent inched up 1.6% to $46.39.

Gold settled down 0.8% at $1,923.10 per ounce. 

The Dollar Index fell by 0.2% at 93.061.


Asia and Australia

The stocks were boosted by the records reached by the American benchmarks amid the possible #COVID-19 vaccine. 

Japan225 reached a six-month high after it added 1.35%.

HongKong45 lost 0.17% after a man was found positive for COVID-19 for the second time, confirming, therefore, the hypothesis that reinfection is possible.

Australia200 gained 0.50% even though the Commonwealth Bank of Australia painted a bleak picture of the post-pandemic economic recovery. 

USD/JPY was up 0.20% to 106.19. 


Europe 

The markets followed its peers steps and ended the day on positive territory. Europe50 was up 0.4%, while UK100 added 0.3%. Germany30 rose 0.6%. 

EUR/USD traded 0.4% higher at $1.18325.

CAPEX.com gives you the possibility to trade everything you want, from CFDs on commodities to forex, to cryptocurrencies! Check-out the website and see what fits you best!

Sources: reuters.com, investing.com


Share this article

This information prepared by capex.com/za is not an offer or a solicitation for the purpose of purchase or sale of any financial products referred to herein or to enter into any legal relations, nor an advice or a recommendation with respect to such financial products.This information is prepared for general circulation. It does not regard to the specific investment objectives, financial situation, or the particular needs of any recipient.You should independently evaluate each financial product and consider the suitability of such a financial product, by taking into account your specific investment objectives, financial situation, or particular needs, and by consulting an independent financial adviser as needed, before dealing in any financial products mentioned in this document.This information may not be published, circulated, reproduced, or distributed in whole or in part to any other person without the Company’s prior written consent.
Past performance is not always indicative of likely or future performance. Any views or opinions presented are solely those of the author and do not necessarily represent those of capex.com/zaJME Financial Services (Pty) Ltd trading as CAPEX.COM/ZA acts as intermediary between the investor and Magnasale Trading Ltd, the counterparty to the contract for difference purchased by the Investor via CAPEX.COM/ZA, authorised & regulated by the Cyprus Securities and Exchange Commission with license number 264/15.  Magnasale Trading Ltd is the principal to the CFD purchased by investors.